Skip to main content

Table 3 Univariate analysis of possible risk factors for local tumor progression

From: Improvement of ablative margins by the intraoperative use of CEUS-CT/MR image fusion in hepatocellular carcinoma

Variables

Number

P-value

Age (<70 years/≥70 years)

117/9

0.508*

Sex (male/female)

114/12

0.464*

HBV/HCV infection (yes/no)

125/1

0.794*

Liver cirrhosis (yes/no)

105/21

0.150*

Child–Pugh grade (A/B)

113/13

0.715*

AFP level (<20 ng/ml/≥20 ng/ml)

69/57

0.699*

Number of tumors (1 or ≥ 1)

75/51

0.764*

Tumor diameter (<30 mm/≥30 mm)

109/17

0.118*

Past treatment history for HCC (yes/no)

58/68

0.496*

Located in the hepatic dome (yes/no)

39/87

0.848*

TACE before ablation (yes/no)

41/85

0.356*

Ablative margin (inadequate/adequate)

83/43

0.014*

  1. *Log–rank test